Lingga, Mary Ann .
HRN: 26-32-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2025
MUPIROCIN 2%, 15G (TUBE)
02/05/2025
02/11/2025
TOPICAL
Pea Size
Od
S/P CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes